Stocksigma LogoStocksigma Logo

Kimia Biosciences Reports Q2'27 Standalone Profit Growth Despite Lower YoY Revenue

Kimia Biosciences reported standalone revenue from operations of ₹2,681.19 lakhs for the quarter ended 30th Sep'26, down 21.14% YoY from ₹3,399.93 lakhs

Kimia Biosciences Reports Q2'27 Standalone Profit Growth Despite Lower YoY Revenue

Kimia Biosciences Ltd · Financial Result · 13 Nov 2026, 10:29 pm

Kimia Biosciences Reports Q2'27 Standalone Profit Growth Despite Lower YoY Revenue Kimia Biosciences reported standalone revenue from operations of ₹2,681.19 lakhs for the quarter ended 30th Sep'26, down 21.14% YoY from ₹3,399.93 lakhs but up 29.39% QoQ from ₹2,072.25 lakhs. Net profit for the period surged 135.21% YoY and 571.25% QoQ to ₹238.76 lakhs, driven by lower raw material consumption costs. Basic and diluted EPS rose to ₹0.50 from ₹0.21 in the year-ago period. Statutory auditors issued an unmodified limited review report on the standalone results.

Original exchange filing (PDF)

More announcements from Kimia Biosciences Ltd

All Kimia Biosciences Ltd announcements